Trends in Approvals of New Drugs With Orphan Designation in the Us (1983-2014)

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.03.1760
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Analysis of the Ultra-Orphan Drugs Approved by the Fda in the Period 1983-2014

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Orphan Drug Approvals in Europe: Historical Review and Trends

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Trends in Approvals and Prices of Oncology Drugs in the United States (1990-2013)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Comparative Analysis of HIV Antiretroviral Drugs Approvals and Prices in the US and Saudi Arabia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Orphan Designation: Brincidofovir, Treatment of Smallpox

Case Medical Research
2019English

Psy180 - Uk Health Technology Assessment of Orphan Drugs for Rare Oncology Versus Rare Disease: Does Orphan Designation Make Any Difference in Hta Process?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Orphan Designation: Pomalidomide, Treatment of Multiple Myeloma

Case Medical Research
2019English

Comparison of the Expedited Programs & Orphan Drug Designation in the Usa & Japan

Indian Research Journal of Pharmacy and Science
2018English

Orphan Designation: Melatonin, Treatment of Perinatal Asphyxia

Case Medical Research
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy